Qube Research & Technologies (QRT)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.6M Sell
312,500
-288,200
-48% -$33.3M 0.04% 542
2025
Q4
$63.2M Sell
600,700
-523,000
-47% -$49.1M 0.06% 392
2025
Q3
$94.3M Sell
1,123,700
-130,300
-10% -$10.7M 0.1% 251
2025
Q2
$99.3M Buy
1,254,000
+982,000
+361% +$78.1M 0.1% 258
2025
Q1
$24.4M Buy
272,000
+65,800
+32% +$6.14M 0.03% 663
2024
Q4
$20.5M Buy
206,200
+95,300
+86% +$9.82M 0.03% 709
2024
Q3
$12.6M Buy
+110,900
New +$13.2M 0.02% 903
2024
Q1
Sell
-25,200
Closed -$2.75M 4727
2023
Q4
$2.75M Sell
25,200
-38,600
-61% -$4.01M 0.01% 1365
2023
Q3
$6.57M Buy
+63,800
New +$6.88M 0.02% 813

Other funds holding MRK

Qube Research & Technologies (QRT)'s MRK Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Merck (MRK) in Q4 2025, closing a stake of 2,063,967 shares — an estimated $194M sold.

Qube Research & Technologies (QRT) first reported a position in MRK in Q1 2018 and held it in 26 quarters. The position peaked at $529M in Q2 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2,063,967 Merck shares in Q4 2025, an estimated $194M.
  • Qube Research & Technologies (QRT) first reported a position in Merck in Q1 2018 and held it in 26 quarters.
  • Qube Research & Technologies (QRT)'s Merck position peaked at $529M in Q2 2024.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.